![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PCDH7 |
Gene summary for PCDH7 |
![]() |
Gene information | Species | Human | Gene symbol | PCDH7 | Gene ID | 5099 |
Gene name | protocadherin 7 | |
Gene Alias | BH-Pcdh | |
Cytomap | 4p15.1 | |
Gene Type | protein-coding | GO ID | GO:0007155 | UniProtAcc | O60245 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5099 | PCDH7 | CA_HPV_1 | Human | Cervix | CC | 3.22e-11 | -3.68e-01 | 0.0264 |
5099 | PCDH7 | CA_HPV_3 | Human | Cervix | CC | 2.37e-03 | -4.27e-02 | 0.0414 |
5099 | PCDH7 | HSIL_HPV_1 | Human | Cervix | HSIL_HPV | 9.69e-06 | -2.91e-01 | 0.0116 |
5099 | PCDH7 | N_HPV_1 | Human | Cervix | N_HPV | 1.91e-05 | -3.07e-01 | 0.0079 |
5099 | PCDH7 | CCI_1 | Human | Cervix | CC | 8.22e-07 | 1.26e+00 | 0.528 |
5099 | PCDH7 | CCI_2 | Human | Cervix | CC | 4.51e-03 | -3.85e-01 | 0.5249 |
5099 | PCDH7 | Tumor | Human | Cervix | CC | 1.81e-03 | -2.34e-01 | 0.1241 |
5099 | PCDH7 | sample3 | Human | Cervix | CC | 8.46e-03 | -1.65e-01 | 0.1387 |
5099 | PCDH7 | L1 | Human | Cervix | CC | 4.78e-09 | -3.85e-01 | 0.0802 |
5099 | PCDH7 | T3 | Human | Cervix | CC | 9.20e-03 | -1.81e-01 | 0.1389 |
5099 | PCDH7 | AEH-subject1 | Human | Endometrium | AEH | 3.74e-13 | 5.13e-01 | -0.3059 |
5099 | PCDH7 | AEH-subject2 | Human | Endometrium | AEH | 1.61e-25 | 7.34e-01 | -0.2525 |
5099 | PCDH7 | AEH-subject5 | Human | Endometrium | AEH | 3.95e-04 | 3.86e-01 | -0.2953 |
5099 | PCDH7 | EEC-subject1 | Human | Endometrium | EEC | 1.99e-10 | 4.59e-01 | -0.2682 |
5099 | PCDH7 | EEC-subject2 | Human | Endometrium | EEC | 1.87e-24 | 7.11e-01 | -0.2607 |
5099 | PCDH7 | EEC-subject3 | Human | Endometrium | EEC | 1.17e-16 | 3.56e-01 | -0.2525 |
5099 | PCDH7 | EEC-subject4 | Human | Endometrium | EEC | 1.66e-02 | 2.21e-01 | -0.2571 |
5099 | PCDH7 | EEC-subject5 | Human | Endometrium | EEC | 1.00e-02 | 2.55e-01 | -0.249 |
5099 | PCDH7 | GSM5276934 | Human | Endometrium | EEC | 3.56e-08 | -3.12e-01 | -0.0913 |
5099 | PCDH7 | GSM5276935 | Human | Endometrium | EEC | 2.87e-19 | 5.91e-01 | -0.123 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0098742 | Cervix | N_HPV | cell-cell adhesion via plasma-membrane adhesion molecules | 17/534 | 273/18723 | 2.26e-03 | 2.11e-02 | 17 |
GO:00987421 | Skin | SCCIS | cell-cell adhesion via plasma-membrane adhesion molecules | 26/919 | 273/18723 | 9.83e-04 | 1.23e-02 | 26 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PCDH7 | SNV | Missense_Mutation | c.1605C>A | p.Phe535Leu | p.F535L | O60245 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-75-6214-01 | Lung | lung adenocarcinoma | Female | Unknown | III/IV | Unknown | Unknown | PD | |
PCDH7 | SNV | Missense_Mutation | novel | c.1515N>G | p.Ile505Met | p.I505M | O60245 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-86-6851-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PCDH7 | SNV | Missense_Mutation | c.2645T>A | p.Ile882Asn | p.I882N | O60245 | protein_coding | deleterious(0) | possibly_damaging(0.844) | TCGA-86-7955-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | etoposide | PD | |
PCDH7 | SNV | Missense_Mutation | c.2589G>T | p.Gln863His | p.Q863H | O60245 | protein_coding | tolerated(0.12) | possibly_damaging(0.601) | TCGA-97-A4M7-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
PCDH7 | SNV | Missense_Mutation | novel | c.2558T>A | p.Ile853Lys | p.I853K | O60245 | protein_coding | deleterious(0) | possibly_damaging(0.601) | TCGA-MN-A4N5-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
PCDH7 | SNV | Missense_Mutation | c.2158C>T | p.Pro720Ser | p.P720S | O60245 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-MP-A4SY-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | PD | |
PCDH7 | SNV | Missense_Mutation | c.77N>T | p.Arg27Cys | p.R27C | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.999) | TCGA-MP-A4T7-01 | Lung | lung adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | ||
PCDH7 | SNV | Missense_Mutation | c.287G>T | p.Gly97Cys | p.G97C | protein_coding | deleterious_low_confidence(0.01) | benign(0.046) | TCGA-MP-A4TD-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | cisplatin | PD | ||
PCDH7 | SNV | Missense_Mutation | novel | c.3095N>C | p.Gly1032Ala | p.G1032A | O60245 | protein_coding | tolerated(0.27) | probably_damaging(1) | TCGA-NJ-A4YQ-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PCDH7 | SNV | Missense_Mutation | c.1868N>G | p.Thr623Ser | p.T623S | O60245 | protein_coding | deleterious(0) | benign(0.139) | TCGA-18-3419-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |